Development Level

Tbio 29 | 11,445
Tchem 14 | 1,598
Tdark 9 | 6,588
Tclin 1 | 613

IMPC Phenotype

embryonic lethality prior to t... 2 | 278
preweaning lethality, complete... 2 | 979
preweaning lethality, incomple... 2 | 499
abnormal heart morphology 1 | 162
abnormal vocalization 1 | 21
cataract 1 | 92
decreased circulating HDL chol... 1 | 68
decreased circulating calcium ... 1 | 36
decreased circulating choleste... 1 | 93
decreased circulating glucose ... 1 | 126
decreased circulating insulin ... 1 | 76
decreased grip strength 1 | 116
decreased leukocyte cell numbe... 1 | 73
decreased mean corpuscular vol... 1 | 79
embryonic lethality prior to o... 1 | 239
hydrometra 1 | 53
increased circulating alkaline... 1 | 122
increased circulating sodium l... 1 | 71
increased grip strength 1 | 41
increased heart rate variabili... 1 | 7
male infertility 1 | 123

Disease

Carcinoma 26 | 11,493
ovarian cancer 26 | 8,520
psoriasis 26 | 6,694
medulloblastoma, large-cell 21 | 6,241
glioblastoma 18 | 5,792
atypical teratoid / rhabdoid tumor 17 | 5,112
lung cancer 17 | 4,740
adult high grade glioma 16 | 3,801
ependymoma 16 | 4,679
invasive ductal carcinoma 15 | 2,951
interstitial cystitis 14 | 2,312
lung adenocarcinoma 14 | 2,716
osteosarcoma 14 | 7,950
group 4 medulloblastoma 13 | 1,855
malignant mesothelioma 13 | 3,232
non-small cell lung cancer 13 | 2,890
Astrocytoma, Pilocytic 11 | 3,081
diabetes mellitus 11 | 1,728
ductal carcinoma in situ 11 | 1,745
group 3 medulloblastoma 11 | 4,104
intraductal papillary-mucinous adenoma (IPMA) 11 | 2,955
pancreatic ductal adenocarcinoma liver metastasis 10 | 1,962
subependymal giant cell astrocytoma 10 | 2,287
Autosomal recessive predisposition 9 | 1,442
Breast cancer 9 | 3,578
cystic fibrosis 9 | 1,696
lung carcinoma 9 | 2,843
primitive neuroectodermal tumor 9 | 3,035
Cancer 8 | 2,499
Schizophrenia 8 | 1,160
active Crohn's disease 8 | 922
astrocytic glioma 8 | 2,597
intraductal papillary-mucinous neoplasm (IPMN) 8 | 3,291
pancreatic cancer 8 | 2,398
active ulcerative colitis 7 | 764
breast carcinoma 7 | 1,638
colon cancer 7 | 1,478
oligodendroglioma 7 | 2,850
ulcerative colitis 7 | 1,819
Atherosclerosis 6 | 291
Coronary artery disease 6 | 268
Pick disease 6 | 1,894
adrenocortical carcinoma 6 | 1,428
cutaneous lupus erythematosus 6 | 1,057
intraductal papillary-mucinous carcinoma (IPMC) 6 | 2,989
tuberculosis 6 | 2,010
Atopic dermatitis 5 | 952
Intellectual disability 5 | 1,016
Kidney cancer 5 | 2,613
posterior fossa group B ependymoma 5 | 416
Bipolar Disorder 4 | 666
Lipid metabolism disorder 4 | 114
Liver Cirrhosis, Experimental 4 | 769
Toxic encephalopathy 4 | 141
dermatomyositis 4 | 966
esophageal adenocarcinoma 4 | 737
nasopharyngeal carcinoma 4 | 1,058
non primary Sjogren syndrome sicca 4 | 891
pediatric high grade glioma 4 | 1,064
pituitary cancer 4 | 1,972
primary pancreatic ductal adenocarcinoma 4 | 1,109
Cardiovascular system disease 3 | 246
Down syndrome 3 | 499
Dull intelligence 3 | 645
Hypercholesterolemia, Familial 3 | 23
Ileocolitis 3 | 5
Low intelligence 3 | 645
Mental Retardation 3 | 645
Mental deficiency 3 | 645
Osteoarthritis 3 | 184
Poor school performance 3 | 645
acute quadriplegic myopathy 3 | 1,158
astrocytoma 3 | 1,146
gastric carcinoma 3 | 807
mucosa-associated lymphoid tissue lymphoma 3 | 484
nephrosclerosis 3 | 333
non-small cell lung carcinoma 3 | 317
Amyotrophic lateral sclerosis 2 | 451
Cerebrovascular disease 2 | 238
Depressive disorder 2 | 409
Epilepsy 2 | 792
Heart disease 2 | 306
Hypercholesterolemia 2 | 44
MAJOR AFFECTIVE DISORDER 2 2 | 22
Neurodegenerative disease 2 | 414
Parkinson's disease 2 | 392
Polycystic ovary syndrome 2 | 360
Seizures 2 | 596
Stomach Neoplasms 2 | 300
chronic lymphosyte leukemia 2 | 204
chronic rhinosinusitis 2 | 512
fibroadenoma 2 | 559
glioblastoma multiforme 2 | 142
juvenile dermatomyositis 2 | 1,187
non diabetic and post-ischemic heart failure 2 | 200
pancreatic carcinoma 2 | 562
sonic hedgehog group medulloblastoma 2 | 467
tuberculosis and treatment for 3 months 2 | 179
type II diabetes mellitus and post-ischemic heart failure 2 | 88
urothelial carcinoma 2 | 318

Tissue

Digestive Tract 52 | 17,369
Endocrine System 50 | 18,159
Female tissues 48 | 17,400
Respiratory system 48 | 16,393
Blood and immune system 47 | 16,909
Skin and soft tissues 47 | 17,230
Liver and Pancreas 46 | 16,750
Male tissues 46 | 17,142
Nervous System 46 | 16,725
Urinary Tract 46 | 16,678
Cardiovascular System 40 | 15,192

Target Family

Enzyme 40 | 4,145
Non-IDG 9 | 12,091
Kinase 2 | 634
Transcription Factor 2 | 1,400

GO Process

phospholipid metabolic process 53 | 53
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Retinoic acid receptor responder protein 3 RARRES3 Tbio Non-IDG -1.84020 71.0 164
Cytosolic phospholipase A2 delta PLA2G4D Tbio Enzyme -0.54284 3.41 45
Cytosolic phospholipase A2 gamma PLA2G4C Tchem Enzyme -1.27690 20.9 63
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 PLCB2 Tbio Enzyme -2.14048 137.8 104
Phospholipid phosphatase 2 PLPP2 Tbio Enzyme -1.34465 21.0 105
Group IIE secretory phospholipase A2 PLA2G2E Tchem Enzyme -0.44734 2.04 30
Protein PROCA1 PROCA1 Tbio Non-IDG -0.54042 3.33 57
Phospholipid phosphatase 5 PLPP5 Tbio Enzyme -0.73719 6.23 78
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 PLCD1 Tchem Enzyme -2.17969 140.9 120
Cytosolic phospholipase A2 epsilon PLA2G4E Tdark Enzyme -0.25773 2.16 47